Searched for
ASTRAZENECA INVESTMENT UK
AstraZeneca India recasts biopharma unitAstraZeneca India has laid off over 125 employees in its biopharmaceutical business unit, including senior managers and sales executives. T...
AstraZeneca threatens to move UK vaccine production to US, FT reportsAstraZeneca has warned it might move its vaccine manufacturing site from the UK to the United States due to stalled discussions with the ne...
Courtroom showdown: European Union takes on AstraZeneca in vaccine rowAstraZeneca's contract signed with the Commission on behalf of EU member states foresaw an initial 300 million doses for distribution among...
Dalal Street on course for the longest weekly streak in a decadeIn the 50-share pack Nifty, M&M was the biggest gainer, up 2.05 per cent. UPL, TCS, HDFC, SBI, Tata Motors, Shree Cement, ITC, Infosys and ...
European shares cheer Brexit trade talks extension; AstraZeneca dropsWith banks in the lead, Europe's benchmark STOXX 600 index rose 0.7% after breaking a five-week winning streak to end 1% lower last week.
AstraZeneca to acquire Alexion in $39 billion dealAlexion shareholders will receive $60 in cash and 2.1243 AstraZeneca American Depositary Shares per Alexion share.
India to get 100 million AstraZeneca's Covid vaccines next month: Serum Institute headIf final-stage trial data show AstraZeneca’s candidate gives effective protection from the virus, the Serum Institute of India Ltd. -- whic...
Bangladesh’s top pharma group & Serum Institute of India join hands for Covid-19 vaccineThe investment amount will be treated as an advance and once the vaccine receives regulatory approvals, SII will include Bangladesh among t...
Serum Institute can supply 400 million doses by December, says CEO Adar PoonawallaPoonawalla said the company plans to make 70 million doses per month and increase this to 100 million. These will be used for phase 3 clini...
AstraZeneca approaches Gilead about potential mergerAstraZeneca Plc has approached rival drugmaker Gilead Sciences Inc. about a potential merger.
Pankaj Patel owned Cadila ups its India game with AZ’s brandsAs part of the agreement, AZ will sell the following brands of Bricarex, Bricarex-A, Bricanyl, Xylocard, Ceriviprime, Prostodin, Partocin a...
AstraZeneca inaugurates global technology centre in ChennaiThe company is also looking to develop additional technology centres with a second GTC planned for San Francisco in 2015.
Pfizer move on AstraZeneca threatens UK science, lawmakers sayPfizer's potential takeover of AstraZeneca poses a threat to British science unless it can give more concrete, enforceable guarantees on jo...
Pfizer boss enters lion's den of UK politics to sell AstraZeneca dealIn Tuesday's sessions lawmakers will also interrogate AstraZeneca's French CEO Pascal Soriot and business minister Vince Cable.
AstraZeneca to close its Bangalore R&D unitThe decision to shut the R&D centre is part of an ongoing global restructuring exercise, said the company that employs over 1,200 people in...
- AstraZeneca planning to delist Indian subsidiary; likely to appoint Merrill Lynch as manager for delisting
AstraZeneca, the world's seventh largest drug maker by sales, is planning to delist its Indian subsidiary, said two people with knowledge o...
- HCL Technologies replaces IBM as IT infra vendor of AstraZeneca
HCL will deliver server virtualisation, storage and backup transformation and implementation of hybrid cloud for the AstraZeneca.